NCT01971580View on ClinicalTrials.gov

The Effects of Ambrisentan on Exercise Capacity in Fontan Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Single Ventricle Fontan Palliation
Interventions
DRUG

Ambrisentan

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT01971580 - The Effects of Ambrisentan on Exercise Capacity in Fontan Patients | Biotech Hunter | Biotech Hunter